These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17046823

  • 1. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.
    Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, Morimoto S, Sasaguri T.
    J Biol Chem; 2006 Dec 15; 281(50):38489-97. PubMed ID: 17046823
    [Abstract] [Full Text] [Related]

  • 2. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
    Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T.
    Exp Cell Res; 2005 Nov 01; 310(2):426-33. PubMed ID: 16153639
    [Abstract] [Full Text] [Related]

  • 3. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
    Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T.
    J Biol Chem; 2003 Mar 14; 278(11):9663-70. PubMed ID: 12522140
    [Abstract] [Full Text] [Related]

  • 4. A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
    Ashford AL, Oxley D, Kettle J, Hudson K, Guichard S, Cook SJ, Lochhead PA.
    Biochem J; 2014 Jan 01; 457(1):43-56. PubMed ID: 24134204
    [Abstract] [Full Text] [Related]

  • 5. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
    Takahashi-Yanaga F, Yoshihara T, Jingushi K, Igawa K, Tomooka K, Watanabe Y, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Sasaguri T.
    Biochem Pharmacol; 2014 Jun 01; 89(3):340-8. PubMed ID: 24670930
    [Abstract] [Full Text] [Related]

  • 6. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.
    Yasmin T, Takahashi-Yanaga F, Mori J, Miwa Y, Hirata M, Watanabe Y, Morimoto S, Sasaguri T.
    Biochem Biophys Res Commun; 2005 Dec 16; 338(2):903-9. PubMed ID: 16243295
    [Abstract] [Full Text] [Related]

  • 7. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.
    Zou Y, Ewton DZ, Deng X, Mercer SE, Friedman E.
    J Biol Chem; 2004 Jun 25; 279(26):27790-8. PubMed ID: 15075324
    [Abstract] [Full Text] [Related]

  • 8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X.
    Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000
    [Abstract] [Full Text] [Related]

  • 9. Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis.
    Tetsuo F, Arioka M, Miura K, Kai M, Kubo M, Igawa K, Tomooka K, Takahashi-Yanaga F, Nishimura F, Sasaguri T.
    Cancer Sci; 2019 Dec 30; 110(12):3761-3772. PubMed ID: 31553107
    [Abstract] [Full Text] [Related]

  • 10. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS, Zhou J, Ong CN, Shen HM.
    Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
    Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM, Gelderblom WC.
    Carcinogenesis; 2000 Aug 08; 21(8):1537-46. PubMed ID: 10910956
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
    Diehl JA, Cheng M, Roussel MF, Sherr CJ.
    Genes Dev; 1998 Nov 15; 12(22):3499-511. PubMed ID: 9832503
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
    Bai J, Nakamura H, Ueda S, Kwon YW, Tanaka T, Ban S, Yodoi J.
    J Biol Chem; 2004 Sep 10; 279(37):38710-4. PubMed ID: 15247282
    [Abstract] [Full Text] [Related]

  • 17. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB.
    J Biol Chem; 2004 Sep 17; 279(38):39541-54. PubMed ID: 15252041
    [Abstract] [Full Text] [Related]

  • 18. GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
    Dal Col J, Dolcetti R.
    Cell Cycle; 2008 Sep 15; 7(18):2813-6. PubMed ID: 18769147
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
    Arioka M, Takahashi-Yanaga F, Kubo M, Igawa K, Tomooka K, Sasaguri T.
    Biochem Pharmacol; 2017 Aug 15; 138():31-48. PubMed ID: 28501501
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.
    Alt JR, Cleveland JL, Hannink M, Diehl JA.
    Genes Dev; 2000 Dec 15; 14(24):3102-14. PubMed ID: 11124803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.